To determine the role of zinc sulphate as a hepatoprotective agent in acetaminophen-induced histopathological changes in animal model. DESIGN: Experimental observational study SETTING: Department of Pharmacology & Pathology, ISRA University, Hyderabad and Department of Pathology, Peoples Medical College, Nawabshah. DURATION: 1st December 2009 to 31 st March 2010. METHODOLOGY: Ninety healthy albino rats (weight 18-32 g) were divided into three main groups (n=30). Group A, which served as control, was maintained on 0.9% normal saline; Group B was given acetaminophen 250 mg/kg as a single dose; Group C was maintained on 1-5 mg/kg zinc sulphate for 1-7 days, before a single dose of acetaminophen 250 mg/kg. Biochemical studies were done 6 hours after acetaminophen administration. At the end of the treatment, all animals were weighed and sacrificed, the liver excised for gross and histopathological examination. Data were statistically evaluated using the Chisquare test. RESULTS: The protective effect of zinc was demonstrated with the reduction in the levels of serum concentration of liver enzymes (aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, and serum sorbitol dehydrogenase), with histopathological changes of centrilobular congestion, and hepatocellular degeneration and necrosis. Histopathological assessment showed typical pathological changes of centrizonal necrosis, steatosis, leukocyte infiltration, portal triaditis, and edema in those animals that received acetaminophen only. Pretreatment of the animals with zinc sulphate led to dosedependent avoidance of these changes. CONCLUSION: Zinc produces a hepatoprotective effect by preventing the ultrastructural injury of hepatic tissue and the disturbance of free amino acid metabolism caused by a toxic dose of acetaminophen.